115
Views
33
CrossRef citations to date
0
Altmetric
Original Articles

POTENTIAL TOXICITY OF NONREGULATED ASBESTIFORM MINERALS: BALANGEROITE FROM THE WESTERN ALPS. PART 3: DEPLETION OF ANTIOXIDANT DEFENSES

, , , , , & show all
Pages 41-49 | Received 06 Jan 2004, Accepted 04 May 2004, Published online: 24 Feb 2007
 

Abstract

The asbestiform fibrous silicate balangeroite exhibits cytotoxic and oxidative properties similar to those exerted by crocidolite asbestos. In human lung epithelial cells A549, balangeroite, like crocidolite, inhibited the pentose phosphate pathway (PPP), one of the main antioxidant intracellular tools; this inhibition was exerted also when PPP was activated by the redox-cycling compound menadione. PPP inhibition may be accounted for by the inhibition of its rate-limiting enzyme, glucose-6-phosphate dehydrogenase (G6PD). Reduced glutathione (GSH), the most important intracellular antioxidant molecule, was decreased by both balangeroite and crocidolite incubation. This effect was not related to any increased content of oxidized glutathione, or to any enhanced efflux of glutathione, suggesting that balangeroite fibers, like crocidolite, might favor the reaction of GSH with other molecules.

The research has been carried out with the financial support of Regione Piemonte, Assessorato all’ Ambiente as part of a muldisciplinary project, entitled “Asbestos Hazard in the Western Alps.” Elena Gazzano, and Francesco Turci are recipients of a doctoral fellowship and Maura Tomatis of a postdoctoral fellowship from Regione Piemonte in the framework of the project.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.